June 2012

FDA doubts Sanofi’s new blood thinner

  • Fri, 06/22/2012 - 2:21pm

The U.S. Food and Drug Administration questions the advantages of Sanofi’s new blood thinner to cancer patients undergoing chemotherapy.
 

FDA Reports Metal-on-Metal Hip Implant Statistics

  • Fri, 06/22/2012 - 12:54pm

The Food and Drug Administration has concerns regarding metal-on-metal hip implants due to the myriad of negative effects they have had on people in the US in the past decade.
 

What a difference a day makes: Pradaxa v. Warfarin

  • Fri, 06/22/2012 - 11:25am

Recent findings reveal that patients with atrial fibrillation facing surgery could forgo their blood thinner therapy for a shorter time while on

Man alleges Actos caused bladder cancer in four months’ time

  • Tue, 06/19/2012 - 2:20pm

Darin Andrews filed a lawsuit against Takeda Pharmaceuticals, claiming the drug company’s negligent manufacturing and marketing of the drug

Pradaxa's bleeding concerns

  • Mon, 06/18/2012 - 3:26pm

Despite its stamp of approval from the FDA, some doctors are hesitant to prescribe a new blood thinner, dabigatran etexilate (

Fentanyl Patch Fatalities

  • Mon, 06/18/2012 - 2:24pm

In the past 15 years, 26 children have suffered accidental exposure to fentanyl patches, according to the FDA and the Institute for Safe Medicine Practices.

Pradaxa forces patients to do their homework

  • Mon, 06/18/2012 - 12:48pm

Pradaxa is proving to be as problematic as its predecessor, warfarin.

FDA OKs new meningitis vaccine for babies

  • Fri, 06/15/2012 - 3:16pm

The U.S.

Yaz and your cardiovascular health

  • Thu, 06/14/2012 - 3:45pm

Women under 50 are not likely to suffer from a heart attack or stroke, but recent studies have shown that taking certain oral contraceptives like

Actos' role in blindness and bladder cancer

  • Thu, 06/14/2012 - 3:11pm

Recent studies reveal that thiazolidinediones like pioglitazone (Actos) and rosiglitazone (Avandia) pose both an increased

Pages